@article{5a46f7c1ae9549d4886fd7b0fff3422f,
title = "Independent Validation of the Hematoma Expansion Prediction Score: A Non-contrast Score Equivalent in Accuracy to the Spot Sign",
author = "{the PREDICT/Sunnybrook CTA Study Group} and Vignan Yogendrakumar and Tim Ramsay and Fergusson, {Dean A.} and Demchuk, {Andrew M.} and Aviv, {Richard I.} and David Rodriguez-Luna and Molina, {Carlos A.} and {Silva Blas}, Yolanda and Imanuel Dzialowski and Adam Kobayashi and Boulanger, {Jean Martin} and Cheemun Lum and Gord Gubitz and Padma Srivastava and Jayanta Roy and Kase, {Carlos S.} and Rohit Bhatia and Hill, {Michael D.} and Magdy Selim and Dar Dowlatshahi",
note = "Funding Information: Michael D. Hill reports personal fees from Merck, non‑financial support from Hoffmann‑La Roche Canada Ltd, grants from Covidien (Medtronic), grants from Boehringer‑Ingleheim, grants from Stryker Inc., grants from Medtronic LLC, grants from NoNO Inc., outside the submitted work; In addition, Hill has a patent Systems and Methods for Assisting in Decision‑Making and Triaging for Acute Stroke Patients pending to US Patent office Number: 62/086,077 and owns stock in Calgary Scientific Incorporated, a company that focuses on medical imaging software, is a director of the Canadian Federation of Neurological Sciences, a not‑for‑profit group and has received grant support from Alberta Innovates Health Solutions, CIHR, Heart & Stroke Foundation of Canada, National Institutes of Neurological Disorders and Stroke; Magdy Selim reports grants from NIH/NINDS, during the conduct of the study and the remaining authors have nothing to disclose. Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.",
year = "2019",
month = aug,
day = "15",
doi = "10.1007/s12028-019-00740-5",
language = "English",
volume = "31",
pages = "1--8",
journal = "Neurocritical Care",
issn = "1541-6933",
publisher = "Humana Press",
number = "1",
}